DelveInsight’s “Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an ...

DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

Teva stock plunged Wednesday — sacrificing an earlier breakout — despite beating third-quarter expectations and raising its guidance.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Reports Q3 revenue $4.3B, consensus $4.12B. Richard Francis, Teva‘s (TEVA) President and CEO, said, “The third quarter of 2024 ...

Attorney General Charity Clark announced two significant multistate settlements with Heritage Pharmaceuticals and Apotex which nationally total $49.1 million. The settlements resolve allegations that ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Reorganizing its generics business strategy to target 60% instead of 80% of drugs coming off patent and reallocating resources to complex generics will help Teva offset base business erosion and ...

On October 31, 2024, the European Commission (EC) fined Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals Europe BV (Teva) ...

As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...

How will the U.S. election results impact healthcare stocks? Seeking Alpha analysts ONeil Trader, BioCGT Investor and Avisol ...